Trypanosoma cruzi immune response modulation decreases microbiota in Rhodnius prolixus gut and is crucial for parasite survival and development.

PloS One
Daniele P CastroEloi S Garcia

Abstract

Trypanosoma cruzi in order to complete its development in the digestive tract of Rhodnius prolixus needs to overcome the immune reactions and microbiota trypanolytic activity of the gut. We demonstrate that in R. prolixus following infection with epimastigotes of Trypanosoma cruzi clone Dm28c and, in comparison with uninfected control insects, the midgut contained (i) fewer bacteria, (ii) higher parasite numbers, and (iii) reduced nitrite and nitrate production and increased phenoloxidase and antibacterial activities. In addition, in insects pre-treated with antibiotic and then infected with Dm28c, there were also reduced bacteria numbers and a higher parasite load compared with insects solely infected with parasites. Furthermore, and in contrast to insects infected with Dm28c, infection with T. cruzi Y strain resulted in a slight decreased numbers of gut bacteria but not sufficient to mediate a successful parasite infection. We conclude that infection of R. prolixus with the T. cruzi Dm28c clone modifies the host gut immune responses to decrease the microbiota population and these changes are crucial for the parasite development in the insect gut.

References

Jul 1, 1992·Acta Physiologica Scandinavica·S Moncada
Feb 1, 1996·The American Journal of Tropical Medicine and Hygiene·C B PumpuniJ C Beier
Jan 1, 1997·Journal of Invertebrate Pathology·N F NogueiraW de Souza
May 16, 2000·Journal of Tissue Viability·S ThomasS Bourgoise
Aug 22, 2000·Parasitology Today·A H Kollien, G A Schaub
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·Z HaoS Aksoy
Aug 11, 2004·Toxicon : Official Journal of the International Society on Toxinology·E S Garcia, P Azambuja
Jan 1, 1991·Parasitology Today·E S Garcia, P Azambuja
Oct 18, 2005·Trends in Parasitology·Patricia AzambujaNorman A Ratcliffe
Mar 21, 2006·Trends in Parasitology·Ana Rivero
Apr 26, 2006·Trends in Parasitology·Nathalie BoulangerCarl Lowenberger
Sep 23, 2006·Experimental Parasitology·Daniele P CastroPatrícia Azambuja
Dec 5, 2006·Journal of Insect Physiology·Eloi S GarciaPatricia Azambuja
Jun 16, 2007·Experimental Parasitology·Daniele P CastroPatrícia Azambuja
Nov 11, 2008·Acta Tropica·G A VallejoG A Schaub
Apr 25, 2009·The Journal of Parasitology·Y CartonA J Nappi
Feb 18, 2010·Experimental Parasitology·Bradford S McGwire, Manjusha M Kulkarni
Aug 31, 2010·Trends in Parasitology·Eloi S GarciaGünter A Schaub
Sep 14, 2010·Memórias do Instituto Oswaldo Cruz·Eloi S GarciaPatrícia Azambuja
Oct 12, 2010·Vector Borne and Zoonotic Diseases·Peter J WaniekCatarina A C Araújo
Jun 24, 2011·Trends in Parasitology·Brian Weiss, Serap Aksoy
May 17, 2014·Memórias do Instituto Oswaldo Cruz·Christiane Santos MatosJoão Carlos Pinto Dias

❮ Previous
Next ❯

Citations

Mar 7, 2014·Parasites & Vectors·Catarina A C AraújoAna M Jansen
Nov 29, 2014·BMC Genomics·Carolyn E RiddellEamonn B Mallon
Nov 10, 2013·PloS One·Luis Caetano M AntunesNicolas Carels
Mar 30, 2013·Developmental and Comparative Immunology·Erick Garcia-GarciaVictor Mulero
Feb 2, 2016·Developmental and Comparative Immunology·Ariadna Sitjà-BobadillaJaume Pérez-Sánchez
Dec 3, 2015·Proceedings of the National Academy of Sciences of the United States of America·Rafael D MesquitaPedro L Oliveira
Nov 19, 2015·Journal of Insect Physiology·Octávio A C TalyuliPedro L Oliveira
Feb 9, 2017·Memórias do Instituto Oswaldo Cruz·Miguel A SaldañaGrant L Hughes
Jun 17, 2015·The American Journal of Tropical Medicine and Hygiene·Jennifer K PetersonOmar Triana Chávez
Sep 14, 2018·PLoS Neglected Tropical Diseases·Michele Souza LimaGeorgia Correa Atella
Nov 22, 2017·Biomédica : revista del Instituto Nacional de Salud·Carlos P PadillaAbraham G Cáceres
Jan 29, 2016·Parasitology·Roberta Carvalho FerreiraAlessandra Aparecida Guarneri
Jun 18, 2015·Bulletin of Entomological Research·A L Flores-VillegasM Cabrera-Bravo
May 7, 2019·PLoS Neglected Tropical Diseases·Andreea WaltmannNatalie M Bowman
May 21, 2019·PLoS Neglected Tropical Diseases·María de Los Milagros CámaraCarlos A Buscaglia
May 11, 2016·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Jens Rolff, Paul Schmid-Hempel
Oct 31, 2019·Parasites & Vectors·Troy J KieranNicole L Gottdenker
Jan 10, 2017·Frontiers in Microbiology·Nicholas J Tobias
Jun 21, 2019·Current Medicinal Chemistry·Alejandra Cecilia SchoijetGuillermo Daniel Alonso
Sep 24, 2020·Microorganisms·Nicolas Salcedo-PorrasCarl Lowenberger
Nov 19, 2013·PLoS Neglected Tropical Diseases·Marcelo S GonzalezCarlos A Buscaglia
Feb 13, 2015·PLoS Neglected Tropical Diseases·Geoffrey A Preidis, Peter J Hotez
Jan 11, 2020·Frontiers in Cellular and Infection Microbiology·Andrea C MesíasM Paola Zago

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
protein
Protein Assay

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.